{"schema_version":"secwatch.filing_event.v1","accession":"0001453687-24-000072","form_type":"8-K","ticker":"RNAC","cik":"0001453687","company_name":"Cartesian Therapeutics, Inc.","filed_at":"2024-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.481139+00:00","generated_at":"2026-06-03T13:43:57.996799+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cartesian regains Nasdaq minimum bid price compliance; delisting risk removed","bullets":["Received deficiency notice Jan 17, 2024 for bid price below $1.00 for 30 consecutive days.","Compliance period granted until July 15, 2024 to cure the deficiency.","On April 19, 2024, Nasdaq confirmed bid price ≥ $1.00 for 10 consecutive days from April 5-18.","Nasdaq considers the matter closed; company remains listed on Nasdaq Global Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001453687-24-000072","json":"https://secwatch.observer/filing/0001453687-24-000072.json","markdown":"https://secwatch.observer/filing/0001453687-24-000072.md","text":"https://secwatch.observer/filing/0001453687-24-000072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453687/000145368724000072/0001453687-24-000072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453687/000145368724000072/rnac-20240419.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T13:43:57.996799+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}